Varlamos, Charalampos
Varytimiadi, Efthymia
Benetou, Despoina-Rafailia
Alexopoulos, Dimitrios
Article History
Received: 3 April 2021
Accepted: 7 November 2022
First Online: 5 December 2022
Declarations
:
: Not applicable.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: Dr. Alexopoulos has received lecturing honoraria/advisory board fees from Astrazeneca, Bayer, Boehringer Ingelheim, Pfizer, Medtronic, Biotronik, Chiesi Hellas. Other authors have no disclosures.